1921
Volume 97, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Recent World Health Organization (WHO) guidelines recommend antiretroviral therapy (ART) for all HIV-infected people; previously CD4+ T lymphocyte quantification (CD4 count) or clinical staging determined eligibility for children ≥ 5 years old in low- and middle-income countries. We examined positive predictive value (PPV) of a rapid diagnostic test (RDT) algorithm and ART eligibility for hospitalized children with newly diagnosed HIV infection. We enrolled 363 hospitalized Malawian children age 2 months to 16 years with two serial positive HIV RDT from 2013 to 2015. Children aged ≤ 18 months whose nucleic acid testing was negative or unavailable were later excluded from the analysis ( = 16). If RNA PCR was undetectable, human immunodeficiency virus (HIV) enzyme immunoassay (EIA) and western blot (WB) were performed. Those with negative or discordant EIA and WB were considered HIV negative and excluded from further analysis ( = 6). ART eligibility was assessed using age, CD4 count, and clinical HIV stage. Among 150 patients with HIV RNA PCR results, 15 had undetectable HIV RNA. Of those, EIA and WB were positive in nine patients and negative or discordant in six patients. PPV of serial RDT was 90% versus RNA PCR alone and 96% versus combined RNA PCR, EIA, and WB. Of all patients aged ≥ 5 years, 8.9% were ineligible for ART under previous WHO guidelines. Improved HIV testing algorithms are needed for accurate diagnosis of HIV infection in children as prevalence of pediatric HIV declines. Universal treatment will significantly increase the numbers of older children who qualify for ART.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.17-0067
2017-12-06
2019-02-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/6/tpmd170067.html?itemId=/content/journals/10.4269/ajtmh.17-0067&mimeType=html&fmt=ahah

References

  1. UNAIDS, 2016. Fact Sheet. Geneva, Switzerland: United Nations.
  2. UNAIDS, 2016. Children and HIV Fact Sheet. Geneva, Switzerland: United Nations.
  3. UNAIDS, 2016. The Prevention Gap Report. Geneva, Switzerland: United Nations.
  4. WHO/UNAIDS, 2014. 2014 Global Update on the Health Sector Response to HIV. Geneva, Switzerland: World Health Organization.
  5. UNAIDS, 2014. The Gap Report. Geneva, Switzerland: United Nations.
  6. UNAIDS, 2013. Global Report: UNAIDS Report on The Global AIDS Epidemic 2013. Geneva, Switzerland: United Nations.
  7. Hsiao NY, Stinson K, Myer L, , 2013. Linkage of HIV-infected infants from diagnosis to antiretroviral therapy services across the Western Cape, South Africa. PLoS One 8: e55308. [Google Scholar]
  8. Malawi Ministry of Health, 2014. Clinical Management of HIV in Children and Adults. Lilongwe, Malawi: Malawi Ministry of Health.
  9. WHO, 2015. Consolidated Guidelines on HIV Testing Services. Geneva, Switzerland: WHO.
  10. WHO, 2010. Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision. Geneva, Switzerland: WHO.
  11. WHO, 2013. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO.
  12. Kagaayi J, Makumbi F, Nakigozi G, Wawer MJ, Gray RH, Serwadda D, Reynolds SJ, , 2007. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. AIDS 21: 12081210. [Google Scholar]
  13. O’Hare B, Milner DA, Jr Newberry L, Pelani I, Malisita K, , 2014. Discordance between clinical and immunological ART eligibility criteria for children in Malawi. BMC Res Notes 7: 666. [Google Scholar]
  14. WHO, 2015. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva, Switzerland: WHO.
  15. WHO, 2016. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO.
  16. Kankasa C, 2009. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr 51: 202208. [Google Scholar]
  17. Chamla D, 2013. Evidence from the field: missed opportunities for identifying and linking HIV-infected children for early initiation of ART. AIDS 27 (Suppl 2): S139S146. [Google Scholar]
  18. Rogerson SR, Gladstone M, Callaghan M, Erhart L, Rogerson SJ, Borgstein E, Broadhead RL, , 2004. HIV infection among paediatric in-patients in Blantyre, Malawi. Trans R Soc Trop Med Hyg 98: 544552. [Google Scholar]
  19. Zwi K, Pettifor J, Soderlund N, Meyers T, , 2000. HIV infection and in-hospital mortality at an academic hospital in South Africa. Arch Dis Child 83: 227230. [Google Scholar]
  20. Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D, , 2009. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS 23: 11631169. [Google Scholar]
  21. Pantaleo G, 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332: 209216. [Google Scholar]
  22. Paul ME, Mao C, Charurat M, Serchuck L, Foca M, Hayani K, Handelsman EL, Diaz C, McIntosh K, Shearer WT, , 2005. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. J Allergy Clin Immunol 115: 848855. [Google Scholar]
  23. Gulia J, Kumwenda N, Li Q, Taha TE, , 2007. HIV seroreversion time in HIV-1-uninfected children born to HIV-1-infected mothers in Malawi. J Acquir Immune Defic Syndr 46: 332337. [Google Scholar]
  24. Gutierrez M, Ludwig DA, Khan SS, Chaparro AA, Rivera DM, Cotter AM, Scott GB, , 2012. Has highly active antiretroviral therapy increased the time to seroreversion in HIV exposed but uninfected children? Clin Infect Dis 55: 12551261. [Google Scholar]
  25. Klarkowski D, Glass K, O’Brien D, Lokuge K, Piriou E, Shanks L, , 2013. Variation in specificity of HIV rapid diagnostic tests over place and time: an analysis of discordancy data using a Bayesian approach. PLoS One 8: e81656. [Google Scholar]
  26. Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O’Brien DP, , 2009. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS One 4: e4351. [Google Scholar]
  27. Shanks L, Siddiqui MR, Kliescikova J, Pearce N, Ariti C, Muluneh L, Pirou E, Ritmeijer K, Masiga J, Abebe A, , 2015. Evaluation of HIV testing algorithms in Ethiopia: the role of the tie-breaker algorithm and weakly reacting test lines in contributing to a high rate of false positive HIV diagnoses. BMC Infect Dis 15: 39. [Google Scholar]
  28. Gray RH, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, Opendi P, Kigozi G, Reynolds SJ, Sewankambo NK, Wawer MJ, , 2007. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ 335: 188. [Google Scholar]
  29. Kroidl I, Clowes P, Mwalongo W, Maganga L, Maboko L, Kroidl AL, Geldmacher C, Machibya H, Hoelscher M, Saathoff E, , 2012. Low specificity of determine HIV1/2 RDT using whole blood in south west Tanzania. PLoS One 7: e39529. [Google Scholar]
  30. Klarkowski D, O’Brien DP, Shanks L, Singh KP, , 2014. Causes of false-positive HIV rapid diagnostic test results. Expert Rev Anti Infect Ther 12: 4962. [Google Scholar]
  31. Gasasira AF, Dorsey G, Kamya MR, Havlir D, Kiggundu M, Rosenthal PJ, Charlebois ED, , 2006. False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria. J Clin Microbiol 44: 30213024. [Google Scholar]
  32. WHO, 2015. HIV Assays: Laboratory Performance and Other Operational Characteristics: Rapid Diagnostic Tests (Combined Detection of HIV-1/2 Antibodies and Discriminatory Detection of HIV-1 and HIV-2 Antibodies): Report 18. Geneva, Switzerland: WHO.
  33. Tu XM, Litvak E, Pagano M, , 1992. Issues in human immunodeficiency virus (HIV) screening programs. Am J Epidemiol 136: 244255. [Google Scholar]
  34. Shanks L, Klarkowski D, O’Brien DP, , 2013. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One 8: e59906. [Google Scholar]
  35. Penazzato M, Crowley S, Mofenson L, Franceschetto G, Nannyonga MM, Mazza A, Giaquinto C, , 2012. Programmatic impact of the evolution of WHO pediatric antiretroviral treatment guidelines for resource-limited countries (Tukula Fenna Project, Uganda). J Acquir Immune Defic Syndr 61: 522525. [Google Scholar]
  36. Lisse I, Samb B, Whittle H, Jensen H, Soumare M, Simondon F, Aaby P, , 1998. Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal. Scand J Infect Dis 30: 1721. [Google Scholar]
  37. Lisse IM, Aaby P, Whittle H, Knudsen K, , 1994. A community study of T lymphocyte subsets and malaria parasitaemia. Trans R Soc Trop Med Hyg 88: 709710. [Google Scholar]
  38. WHO, 2013. Data Repository Causes of Child Mortality. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/gho/child_health/mortality/causes/en/. Accessed March 25, 2015.
  39. Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P, , 2008. Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines. AIDS 22: 18591867. [Google Scholar]
  40. Hochman SE, 2015. Fatal pediatric cerebral malaria is associated with intravascular monocytes and platelets that are increased with HIV coinfection. MBio 6: e01390e01415. Erratum in: MBio 2016;7(1). [Google Scholar]
  41. Bronzan RN, 2007. Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 195: 895904. [Google Scholar]
  42. Kranzer K, Meghji J, Bandason T, Dauya E, Mungofa S, Busza J, Hatzold K, Kidia K, Mujuru H, Ferrand RA, , 2014. Barriers to provider-initiated testing and counselling for children in a high HIV prevalence setting: a mixed methods study. PLoS Med 11: e1001649. [Google Scholar]
  43. UNAIDS/WHO, 2013. Working Group on Global HIV/AIDS and STI Surveillance: Paediatric HIV Surveillance Among Infants and Children Less Than 18 Years of Age. Geneva, Switzerland: World Health Organization.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0067
Loading
/content/journals/10.4269/ajtmh.17-0067
Loading

Data & Media loading...

Supplemental Figure

  • Received : 27 Jan 2017
  • Accepted : 25 Jun 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error